Elon Musk

The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.

The tech giant will offer access to the LLM for enterprise use as regulatory scrutiny mounts over the model’s data practices and medical diagnostic claims.

The terms align with the company's brain-computer interface technologies aimed at restoring vision and enabling mind-controlled device use.

OpenAI cofounder Sam Altman says the company "is not for sale."  

Musk revealed on X that the SEC has reopened its investigation into Neuralink, sharing a letter from his attorney addressed to the commission's chair.

Blindsight is an experimental implant aimed at restoring vision in individuals who have lost sight in both eyes.

Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.

One of the tidbits in Ashlee Vance's much-talked about Elon Musk biography is that the Musk brothers conceived of, and quickly rejected, an idea that would have put them at the forefront of the digital health space way back in 1994.